|

货币单位:美元(USD)

OncoMed Pharmaceuticals, Inc. (omed)

实时(?):

盘后(?):

读取中...

-- (--%)

开盘价:--	最高价:--	最低价:--	52周最高价:--	52周最低价:--
成交量:--	平均成交量:--	市值:--	市盈率:--	预期市盈率:--
每股收益:--	贝塔系数:--	股息:--	收益率:--	总股本:--

提示:交易结束

Denise Vera Scots-Knight	Denise Vera Scots-Knight is the founder and CEO of Mereo BioPharma Group Plc. She is currently a director at Mereo Biopharma 3 Ltd., Mereo BioPharma 2 Ltd., Mereo BioPharma 4 Ltd., and OncoMed Pharmaceuticals, Inc. She is also an independent director at Elanco Animal Health, Inc. She was also a trustee at British Heart Foundation. Dr. Scots-Knight has an undergraduate degree from the University of California, Berkeley, and undergraduate and doctorate degrees from the University of Birmingham. She founded Mereo BioPharma Group Plc in 2015.

Denise Vera Scots-Knight

Denise Vera Scots-Knight is the founder and CEO of Mereo BioPharma Group Plc. She is currently a director at Mereo Biopharma 3 Ltd., Mereo BioPharma 2 Ltd., Mereo BioPharma 4 Ltd., and OncoMed Pharmaceuticals, Inc. She is also an independent director at Elanco Animal Health, Inc. She was also a trustee at British Heart Foundation. Dr. Scots-Knight has an undergraduate degree from the University of California, Berkeley, and undergraduate and doctorate degrees from the University of Birmingham. She founded Mereo BioPharma Group Plc in 2015.